Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the P2Et Extract Obtained From Caesalpinia Spinosa in the Symptomatic Treatment of Subjects With COVID-19 at the Hospital Universitario San Ignacio, Colombia.

NCT04410510 is registered in ClinicalTrials.gov with Hospital Universitario San Ignacio as lead sponsor.

NCT NCT04410510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04410510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the P2Et Extract Obtained From Caesalpinia Spinosa in the Symptomatic Treatment of Subjects With COVID-19 at the Hospital Universitario San Ignacio, Colombia.
Lead sponsor
Hospital Universitario San Ignacio
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 30, 2020
Completion date
November 30, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, covid, covid19, sars-cov 2